Skip to main content
. Author manuscript; available in PMC: 2019 Jul 24.
Published in final edited form as: Anticancer Res. 2018 Sep;38(9):5247–5251. doi: 10.21873/anticanres.12849

Table II.

Maximum grade 3–5 adjuvant paclitaxel attributable toxicities in 12 assessable patients.

Adverse event Grade
3 4 5
Lymphocyte count decreased 4 1 0
Neutrophil count decreased 1 0 0
White blood cell count decreased 2 0 0